{"database": "lobbying", "table": "lobbying_activities", "rows": [[3183532, "163f69aa-478a-4b01-a55b-dcf0ce95f3cc", "2T", "PORT SIDE STRATEGIES, LLC", 401105394, "NEW VENTURE FUND", 2024, "second_quarter", "PHA", "H.R.4895 - Lowering Drug Costs for American Families Act - in support. Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, null, 0, 1, "2024-05-16T21:31:12-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3183532"], "units": {}, "query_ms": 20.86040994618088, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}